Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- 1 April 2010
- journal article
- review article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 167 (4) , 388-396
- https://doi.org/10.1176/appi.ajp.2009.08121873
Abstract
Dopamine D2 receptor antagonism is a unifying property of all antipsychotic drugs in clinical use. Remarkably, the effector molecules through which these medications exert their actions rem...Keywords
This publication has 65 references indexed in Scilit:
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- A complex interplay between Akt, TSC2 and the two mTOR complexesBiochemical Society Transactions, 2009
- PI3K/Akt: getting it right mattersOncogene, 2008
- Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortexLearning & Memory, 2008
- Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychoticsProceedings of the National Academy of Sciences, 2008
- Association Study of Wnt Signaling Pathway Genes in Bipolar DisorderArchives of General Psychiatry, 2008
- Chibby cooperates with 14-3-3 to regulate β-catenin subcellular distribution and signaling activityThe Journal of cell biology, 2008
- Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humansJournal of Clinical Investigation, 2008
- The role of GSK‐3 in synaptic plasticityBritish Journal of Pharmacology, 2008
- Akt Participation in the Wnt Signaling Pathway through DishevelledJournal of Biological Chemistry, 2001